Episode
Dipeptides and Tripeptides: The Emerging Frontier of Collagen Science
- Published
- May 13, 2026
- Duration seconds
- 357
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/dr-joseph-mercola-take-control-of-your-health-402388/episodes/dipeptides-and-tripeptides-the-emerging-frontier-of-collagen-science/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/dr-joseph-mercola-take-control-of-your-health-402388/dipeptides-and-tripeptides-the-emerging-frontier-of-collagen-science.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Standard collagen supplements get broken down to individual amino acids during digestion, but specific di- and tripeptides resist digestive enzymes, enter your bloodstream intact, and may act as signaling molecules that stimulate collagen production, fibroblast activity, and hyaluronic acid synthesis German company Gelita produces target-specific bioactive collagen peptide formulations for joints, skin, and bone, each backed by randomized, placebo-controlled clinical trials The Japanese company Nitta Gelatin first identified these key bioactive dipeptides from within the collagen peptide molecule over a decade ago, and their Replenwell line contains up to 30 times more bioactive dipeptides than standard collagen A 2024 five-arm multicenter randomized controlled trial showed that 2.5 grams of concentrated bioactive collagen peptides matched the efficacy of 10 grams of conventional collagen — a four-fold potency advantage Gelita's consumer-available hydrolysate powder — roughly $40 for a pound — is currently a practical option, though a commonly studied intake is about 10 grams per day